Mahajan Labs and screening.

Mahajan Imaging & Labs has reported a 32% increase in cancer-related diagnostic investigations across its Delhi-NCR centres between June 2025 and June 2026, highlighting the growing importance of preventive healthcare and early cancer detection in India.

The findings were presented during a webinar on ‘Prevention and Early Detection of Cancer’, where leading oncologists, radiologists, and laboratory experts called for organised cancer screening to become a routine part of healthcare rather than relying on symptom-driven diagnosis. Experts emphasised that early detection remains one of the most effective ways to improve survival rates and reduce the burden of cancer.

The diagnostic network recorded a significant rise in preventive screening during the study period, with Pap Smear tests increasing by 83%, Prostate-Specific Antigen (PSA) tests by 280%, and Mammography examinations by 26%. However, specialists noted that despite growing awareness, many cancers in India continue to be diagnosed only after symptoms develop.

Also Read: Glenmark Launches Generic Sugammadex Injection in US, Expands Hospital Injectables Portfolio


Mahajan Imaging & Labs also reported conducting 5,063 breast imaging examinations, including mammography, breast MRI and ultrasound, with 411 cases requiring further clinical evaluation. Similarly, 192 of the 600 prostate MRI examinations revealed suspicious findings suggestive of clinically significant prostate cancer. To strengthen advanced cancer diagnostics, the organisation has established a dedicated Whole Body MRI Centre in Gurugram equipped with an AI-enabled wide-bore 3 Tesla MRI system.

Dr. Harsh Mahajan, Founder & Chairman, Mahajan Imaging & Labs, said India must move towards organised screening programmes supported by public awareness, workplace health initiatives and policy interventions. Experts concluded that expanding access to quality diagnostics and evidence-based screening programmes will play a crucial role in reducing cancer mortality and improving long-term patient outcomes.


Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!

Related News


whatsapp--v1 JOIN US
whatsapp--v1